Source: Annual Congress 2002 - Thoracic oncology: clinical management
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Lavole, P. Giraud, Y. De Rycke, N. Mounier, B. Milleron, J. M. Cosset (Paris, France). Estimation of the mediastinal involvement probability in lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?. Eur Respir J 2002; 20: Suppl. 38, 1185

Member's Comments

No comment yet.

Related content which might interest you: Impact of 3D conformal radiotherapy on lung function of patients with lung cancer: A prospective study Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Clinical impact of irradiated lung volumetric modeling in adjuvant breast radiotherapy (RT) Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Centrally located lung cancer and risk of occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software Source: Eur Respir J, 53 (5) 1802220; 10.1183/13993003.02220-2018 Year: 2019 Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 HDR endobronchial brachytherapy (HDR-BT) in the management of advanced lung cancer – comparison of different protocols Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Prodromal face of a study: High dose rate endobronchial brachytherapy (HDERB) as a first step introductory treatment of a multimodality therapy approach in non operable NSCLC with endobronchial obstruction Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Attenuation change of lung nodules according to variation of examination techniques in low dose CT using iterative reconstruction: A phantom study Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Salvage lung resection for local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 Optimal integration of chemo- and radiotherapy in small cell lung cancer Source: Annual Congress 2008 - PG6 - Thoracic oncology: new treatments for thoracic malignancies (other than nonsmall cell lung cancer) Year: 2008 Results of stereotactic radiation therapy (SRT) on unique cerebral metastases from lung adenocarcinomas Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Mediastinal staging in lung cancer: A rational approach Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Radiographic findings after stereotactic radiotherapy for lung carcinoma: retrospective analysis of 90 patients Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 The estimations of two regimenes of radiation of brain metastases in patients with primary lung cancer Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007 Impact of endoscopic ultrasound in the staging of lung cancer patients: does lymph node size matter? Source: Eur Respir J 2007; 30: Suppl. 51, 452s Year: 2007 Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Endoscopic placement of fiducial markers for real-time tumor-tracking radiotherapy in 50 patients with lung cancer: A feasibility study Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Estimation of the doses of ionizing radiation related to diagnostic and follow-up imaging in patients with solitary pulmonary nodules Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Biological factors predicting response to chemotherapy (CT) in advanced non small cell lung cancer (NSCLC): A feasibility study on the collection of tissue Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010 Complete endosonographic nodal staging of lung cancer in patients eligible for stereotactic ablative radiotherapy (STAGE study NCT02997449) Source: International Congress 2017 – Interventional pulmonology highlights 2017 Year: 2017